Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 529 KRW -2.76% Market Closed
Market Cap: ₩62.7B

Wall Street
Price Targets

Price Targets Summary
Orient Bio Inc

There are no price targets for Orient Bio Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Orient Bio Inc Competitors:
Price Targets
MNPR
Monopar Therapeutics Inc
95% Upside
SDA
Goldenbridge Acquisition Ltd
171% Upside

Revenue
Forecast

-4% / Year
Past Growth
62% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-4% / Year
Past Growth
62% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Orient Bio Inc's revenue is -4%. The projected CAGR for the next 10 years is 62%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Orient Bio Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Orient Bio Inc's stock price target?
Not Available

Orient Bio Inc doesn't have any price targets made by Wall Street professionals.

What is Orient Bio Inc's Revenue forecast?
Projected CAGR
62%

For the last 13 years the compound annual growth rate for Orient Bio Inc's revenue is -4%. The projected CAGR for the next 10 years is 62%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett